Cargando…
Lactate dehydrogenase level as a COVID-19 severity marker
Autores principales: | Szarpak, Lukasz, Ruetzler, Kurt, Safiejko, Kamil, Hampel, Michal, Pruc, Michal, Kanczuga - Koda, Luiza, Filipiak, Krzysztof Jerzy, Jaguszewski, Milosz Jaroslaw |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666711/ https://www.ncbi.nlm.nih.gov/pubmed/33246860 http://dx.doi.org/10.1016/j.ajem.2020.11.025 |
Ejemplares similares
-
Efficacy and safety of hypertonic saline solutions fluid resuscitation on hypovolemic shock: A systematic review and meta-analysis of randomized controlled trials
por: Safiejko, Kamil, et al.
Publicado: (2022) -
Correlation between takotsubo cardiomyopathy and SARS-CoV-2 infection
por: Szarpak, Lukasz, et al.
Publicado: (2021) -
COVID-19 in pediatric patient
por: Szarpak, Lukasz, et al.
Publicado: (2021) -
Diagnostic value of lactate dehydrogenase in COVID-19: A systematic review and meta-analysis
por: Fialek, Bartosz, et al.
Publicado: (2022) -
Kawasaki disease shock syndrome or toxic shock syndrome in children and the relationship with COVID-19
por: Pruc, Michal, et al.
Publicado: (2020)